HRT Financial’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.8M Buy
368,510
+193,981
+111% +$13.2M 0.05% 336
2026
Q1
$11.3M Buy
+174,529
New +$12.3M 0.03% 574
2025
Q4
– Sell
-240,557
Closed -$17.6M – 3506
2025
Q3
$17.6M Sell
240,557
-226,513
-48% -$15M 0.06% 221
2025
Q2
$24.3M Buy
467,070
+397,985
+576% +$22.6M 0.11% 129
2025
Q1
$4.41M Buy
+69,085
New +$4.01M 0.03% 475
2024
Q3
– Sell
-9,155
Closed -$479K – 2714
2024
Q2
$479K Buy
+9,155
New +$401K ﹤0.01% 1318
2024
Q1
– Sell
-78,318
Closed -$2.89M – 2612
2023
Q4
$2.89M Sell
78,318
-3,616
-4% -$136K 0.02% 502
2023
Q3
$3.13M Buy
81,934
+50,127
+158% +$2.05M 0.03% 447
2023
Q2
$1.15M Sell
31,807
-41,822
-57% -$1.43M 0.01% 868
2023
Q1
$2.81M Buy
73,629
+11,067
+18% +$519K 0.03% 448
2022
Q4
$3.56M Buy
62,562
+44,817
+253% +$2.29M 0.05% 366
2022
Q3
$701K Sell
17,745
-60,629
-77% -$2.68M 0.01% 1235
2022
Q2
$3.45M Buy
+78,374
New +$3.39M 0.04% 364
2022
Q1
– Sell
-35,547
Closed -$1.43M – 3391
2021
Q4
$1.43M Buy
+35,547
New +$1.33M 0.01% 870
2021
Q2
– Sell
-21,092
Closed -$879K – 3115
2021
Q1
$879K Buy
+21,092
New +$963K 0.01% 1280
2020
Q1
– Sell
-13,789
Closed -$244K – 991
2019
Q4
$244K Sell
13,789
-6,817
-33% -$118K 0.01% 849
2019
Q3
$319K Buy
+20,606
New +$339K 0.02% 904

Other funds holding HALO

HRT Financial's HALO Position: Q2 2026 in Review

HRT Financial increased its Halozyme (HALO) stake by 111% in Q2 2026, buying an estimated $13.2M and bringing the position to 368,510 shares worth $28.8M. The position accounts for 0.05% of the portfolio, ranked #336.

HRT Financial first reported a position in HALO in Q3 2019 and has held it in 17 quarters since. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • HRT Financial held 368,510 shares of Halozyme worth $28.8M as of Q2 2026.
  • HRT Financial bought 193,981 Halozyme shares in Q2 2026, an estimated $13.2M.
  • Halozyme made up 0.05% of HRT Financial's portfolio in Q2 2026, its #336 holding.
  • HRT Financial first reported a position in Halozyme in Q3 2019 and has held it in 17 quarters since.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.